Kimberly A. Curseen, MD, will lead Winship's Palliative Medicine Program.
Kimberly A. Curseen, MD, has been named director of the Palliative Medicine Program at Winship Cancer Institute of Emory University, effective Feb. 1. In this new role, Curseen, who is associate professor of medicine at Emory University School of Medicine in the Division of Palliative Medicine and director of supportive and palliative care outpatient services at Emory Healthcare, will provide oversight and direction for palliative medicine research and clinical services at Winship, collaborating with leaders across the health system to expand and strengthen the care experience for patients with cancer.
"I am thrilled to welcome Dr. Curseen to this role, with her extensive expertise, leadership experience and track record of driving improvements in supportive oncology care across our health system," says Suresh Ramalingam, MD, Winship's executive director. "Dr. Curseen is ideally suited to lead this important program, which provides vital services and facilitates essential research that gives us more tools to provide the best possible care for our patients."
Board certified in internal medicine, geriatrics and palliative care, Curseen joined Emory in 2015 and has led Winship’s Supportive Oncology Clinic since that time. Her clinical practice focuses on providing multidisciplinary physical, emotional and spiritual care for patients with cancer and assisting patients with complex decision-making. She is a Board Member of the American Academy of Hospice and Palliative Medicine, carries the clinical distinction of Eminent Clinician, serves as co-chair of the Georgia Cancer Consortium Palliative Care Workgroup, and was the first and continues to be named one of Atlanta's "Top Doctors" in Palliative Medicine by Atlanta magazine. She also serves on the board of directors of TOUCH, The Black Breast Cancer Alliance, an organization dedicated to driving collaborative efforts in science and outreach to improve outcomes for Black women diagnosed with breast cancer. A member of Winship’s Cancer Prevention and Control Research Program, Curseen focuses her research on developing novel approaches to treating cancer pain and understanding the impact of implicit bias in the delivery of high-quality, equitable care.
"I am extremely honored and excited to step into this new role for Winship Cancer Institute," says Curseen. "I feel fortunate to be a part of a cancer institute that is devoted both to research and to providing compassionate and excellent patient-centered care. I look forward to continuing to support ongoing research in supportive oncology."